Evonik Industries AG

EVK

DE000EVNK013

Specialty Chemicals

Market Closed - Xetra Other stock markets 11:35:26 2024-04-24 am EDT			5-day change	1st Jan Change
19.1 ^EUR	-0.52%		-0.05%	+3.24%

Apr. 19	Jefferies raises target for Evonik to €20 - 'Hold'	DP
Apr. 19	EVONIK : Jefferies reaffirms its Neutral rating	ZD

Evonik Industries : strengthens partnership with BioNTech on COVID-19 vaccine

February 11, 2021 at 04:41 am EST

Robert Brown

Phone: +1 973 929-8812

Mobile: +1 973 906-4635

E-mail

Attachments

Original document
Permalink

Disclaimer

Evonik Industries AG published this content on 11 February 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 February 2021 09:40:01 UTC.

Latest news about Evonik Industries AG

Jefferies raises target for Evonik to €20 - 'Hold'	Apr. 19	DP
EVONIK : Jefferies reaffirms its Neutral rating	Apr. 19	ZD
EVONIK : Goldman Sachs reaffirms its Neutral rating	Apr. 18	ZD
EVONIK : DZ Bank reiterates its Neutral rating	Apr. 17	ZD
EVONIK : Warburg Research gives a Buy rating	Apr. 17	ZD
EVONIK : Deutsche Bank reiterates its Buy rating	Apr. 17	ZD
Evonik still in demand - end of correction possible	Apr. 16	DP
EVONIK : JP Morgan maintains a Buy rating	Apr. 16	ZD
EVONIK : Receives a Buy rating from Barclays	Apr. 16	ZD
EVONIK : Gets a Neutral rating from UBS	Apr. 16	ZD
EVONIK : Jefferies sticks Neutral	Apr. 16	ZD
Evonik beats market expectations with Q1 core profit	Apr. 16	RE
3D Systems Receives US FDA Clearance for 3D-Printed Cranial Implant	Apr. 15	MT
EVONIK : JP Morgan reiterates its Buy rating	Apr. 12	ZD
Factbox-European companies cut jobs as economy sputters	Apr. 10	RE
Citi recommends Wacker Chemie and Evonik - BASF, Lanxess 'Neutral'	Apr. 08	DP
EVONIK : Deutsche Bank gives a Buy rating	Mar. 28	ZD
EVONIK : Goldman Sachs withdraws its Sell rating	Mar. 26	ZD
Chemical industry sees first signs of recovery after crisis year	Mar. 15	DP
Germany's chemicals lobby cuts 2024 outlook as price pressures persist	Mar. 15	RE
How companies are responding to attacks on ships in the Red Sea	Mar. 14	RE
EVONIK : Warburg Research keeps its Buy rating	Mar. 13	ZD
EU development bank provides €500 million loan to chemicals group Evonik	Mar. 13	DP
New claim instrument for climate protection contracts launched	Mar. 12	DP
Mood in German chemicals industry slightly improves in February - Ifo	Mar. 12	RE

Chart Evonik Industries AG

Duration

Period

More charts

Company Profile

Evonik Industries AG is a Germany-based specialty chemicals company. The Company engages in the development, construction, distribution and trade of scientific equipment, chemicals and accessories for use in the fields of life sciences and biotechnology.

Sector

Specialty Chemicals

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

MDAX

More about the company

Income Statement Evolution

More financial data

Ratings for Evonik Industries AG

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

19.2 EUR

Average target price

20.7 EUR

Spread / Average Target

+7.81%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
EVONIK INDUSTRIES AG	+3.24%	9.57B
ECOLAB INC.	+11.31%	62.8B
SIKA AG	-5.19%	45.4B
GIVAUDAN SA	+15.01%	40.32B
FUJIFILM HOLDINGS CORPORATION	+20.63%	25.83B
EMS-CHEMIE HOLDING AG	+5.07%	18.21B
CELANESE CORPORATION	+0.04%	17.41B
SYMRISE AG	+4.48%	15.64B
POSCO FUTURE M CO., LTD.	-17.27%	15.51B
ALBEMARLE CORPORATION	-20.22%	13.42B

Other Specialty Chemicals

Evonik Industries AG

Equities

EVK

DE000EVNK013

Specialty Chemicals

Evonik Industries : strengthens partnership with BioNTech on COVID-19 vaccine

EPS Revisions